Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportClinical Science

Isolated and non-isolated cardiac sarcoidosis, with differences in cardiac FDG uptake but similar prognosis

Koichiro Kaneko, Michinobu Nagao, Atsushi Yamamoto, Yuka Matsuo, Akiko Sakai, Eri Watanabe and Shuji Sakai
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 3353;
Koichiro Kaneko
1Tokyo Women's Medical University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michinobu Nagao
2Department of Diagnostic Imaging & Nuclear Medicine, Tokyo Women’s Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsushi Yamamoto
3Department of Cardiology, Tokyo Women’s Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuka Matsuo
2Department of Diagnostic Imaging & Nuclear Medicine, Tokyo Women’s Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akiko Sakai
3Department of Cardiology, Tokyo Women’s Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eri Watanabe
3Department of Cardiology, Tokyo Women’s Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuji Sakai
2Department of Diagnostic Imaging & Nuclear Medicine, Tokyo Women’s Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

3353

Introduction: We divided patients with cardiac sarcoidosis (CS) into isolated type (ICS) and non-isolated type (NICS), and investigated 18F-FDG (FDG) PET/CT findings of cardiac lesions and their prognosis.

Methods: 31 ICS patients (21men and 10 women) and 92 NICS patients (26 men and 66 women) were enrolled in this study. We compared pre-treatment FDG-PET/CT finding, treatment response, and the occurrence of recurrence and major adverse cardiac event (MACE) between ICS and NICS patients.

Results: Focal accumulation pattern was dominantly observed than focal on diffuse (FD) pattern in both ICS (74.1%) and NICS (64.1%) patients. Right ventricular involvement was significantly frequent in NICS patients than ICS patients (44.6% vs. 0.03%, p < 0.0001). SUVmax and cardiac metabolic activity were significantly higher in NICS patients than ICS patients (SUVmax, 8.9±4.2 vs. 4.8±2.1, p < 0.0001; cardiac metabolic activity, 54.9±69.5cm3 vs. 24.4±46.3cm3, p < 0.0001). Treatment responses were better in cardiac lesions than in extra-cardiac lesions, and the disappearance rate of FDG accumulation after treatment was significantly higher in cardiac lesions (72.2% for ICS, 77.1% for NCIS) than extra-cardiac lesions (34.0%, p < 0.001 for both). However, the recurrence rates were similar among cardiac lesions (30.8% for ICS, 40.5% for NCIS) and extra-cardiac lesions (37.5%) during follow-up period (> 2 years). MACE occurred in 33.3% of ICS patients, and 35.7% of NICS patients, and no significant difference was found between the two groups.

Conclusions: Cardiac lesion in NICS showed more intense and more extensive accumulation on FDG-PET/CT than that in ICS. However, the two groups showed similar prognosis.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Isolated and non-isolated cardiac sarcoidosis, with differences in cardiac FDG uptake but similar prognosis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Isolated and non-isolated cardiac sarcoidosis, with differences in cardiac FDG uptake but similar prognosis
Koichiro Kaneko, Michinobu Nagao, Atsushi Yamamoto, Yuka Matsuo, Akiko Sakai, Eri Watanabe, Shuji Sakai
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3353;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Isolated and non-isolated cardiac sarcoidosis, with differences in cardiac FDG uptake but similar prognosis
Koichiro Kaneko, Michinobu Nagao, Atsushi Yamamoto, Yuka Matsuo, Akiko Sakai, Eri Watanabe, Shuji Sakai
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3353;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Quantification of hand blood flow by Rubidium-82 positron emission tomography
  • 18F-FDG PET/CT in the management of patients with primary cardiac angiosarcoma
  • Impact of Rubidium Imaging Availability on Management of Patients with Acute Chest Pain
Show more Clinical Science

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire